Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$60.7M Sell
1,076,236
-19,034
-2% -$1.02M 0.04% 432
2014
Q2
$58.2M Sell
1,095,270
-3,451
-0.3% -$183K 0.05% 394
2014
Q1
$57.4M Sell
1,098,721
-3,121,265
-74% -$158M 0.05% 366
2013
Q4
$226M Buy
4,219,986
+378,023
+10% +$19.5M 0.21% 101
2013
Q3
$195M Buy
3,841,963
+504,574
+15% +$25.7M 0.2% 108
2013
Q2
$172M Buy
+3,337,389
New +$178M 0.2% 96

Other funds holding SNY

UBS's SNY Position: Q3 2014 in Review

UBS reduced its Sanofi (SNY) stake by 1.7% in Q3 2014, selling an estimated $1.02M and leaving 1,076,236 shares worth $60.7M. The position accounts for 0.04% of the portfolio, ranked #432.

UBS first reported a position in SNY in Q2 2013 and has held it in 6 quarters since. The position peaked at $226M in Q4 2013. 502 funds tracked by Wall St. Rank hold SNY as of Q3 2014.

  • UBS held 1,076,236 shares of Sanofi worth $60.7M as of Q3 2014.
  • UBS sold 19,034 Sanofi shares in Q3 2014, an estimated $1.02M.
  • Sanofi made up 0.04% of UBS's portfolio in Q3 2014, its #432 holding.
  • UBS first reported a position in Sanofi in Q2 2013 and has held it in 6 quarters since.
  • UBS's Sanofi position peaked at $226M in Q4 2013.
  • 502 funds tracked by Wall St. Rank held Sanofi as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.